Huai Gao

Title: Huai Gao - Innovator in Immunosuppressive Compounds

Introduction

Huai Gao is a notable inventor based in Groton, MA (US). She has made significant contributions to the field of immunology through her innovative research and development of novel compounds. Her work focuses on creating aromatic compounds that can inhibit immune responses, which has important implications for organ and bone marrow transplantation.

Latest Patents

Huai Gao holds a patent for "Aromatic compounds for inhibiting immune response." This patent describes novel compounds wherein R.sup.1 to R.sup.13 are independently selected from C.sub.2 -C.sub.4 linear and branched alkyls, H, NH.sub.2, CH.sub.3, OR.sup.14, fluorine, chlorine, iodine, NO.sub.2, CF.sub.3, NHCOCH.sub.3, NHCOOtBu, NHR.sup.15, NR.sup.16 R.sup.17, and phenyl. These compounds are designed for use as immunosuppressive agents to prevent or significantly reduce graft rejection in organ and bone marrow transplantation. Additionally, they can serve as immunosuppressant drugs for T-lymphocyte mediated autoimmune diseases, such as diabetes, and may be useful in alleviating psoriasis and contact dermatitis. The compounds also have potential applications in antiproliferation and gene therapy.

Career Highlights

Huai Gao is currently employed at Procept Corporation, where she continues her research and development efforts. Her innovative work has led to advancements in the field of immunology, particularly in the area of immunosuppressive therapies.

Collaborations

Some of her notable coworkers include Timothy D Ocain and Jeffrey I Krieger. Their collaborative efforts contribute to the ongoing research and development of new therapeutic solutions.

Conclusion

Huai Gao's contributions to the field of immunology through her innovative patents and research at Procept Corporation highlight her role as a leading inventor in the development of immunosuppressive agents. Her work has the potential to significantly impact the treatment of autoimmune diseases and improve outcomes for organ transplant recipients.